Metabolic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the metabolic deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of 547 metabolic deals from 2019 to 2024.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of metabolic dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in metabolic dealmaking.
Chapter 3 covers the financial deal terms for deals signed in the metabolic field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.
Chapter 4 provides a review of the top 25 most active biopharma companies in metabolic dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive and detailed review of metabolic deals signed and announced since 2019 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of metabolic deals listed by therapeutic target.
The report also includes numerous table and figures that illustrate the trends and activities in metabolic deal making since 2019.
In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Metabolic Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.
Fully revised and updated, the report provides details of 547 metabolic deals from 2019 to 2024.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of metabolic dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in metabolic dealmaking.
Chapter 3 covers the financial deal terms for deals signed in the metabolic field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.
Chapter 4 provides a review of the top 25 most active biopharma companies in metabolic dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive and detailed review of metabolic deals signed and announced since 2019 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of metabolic deals listed by therapeutic target.
The report also includes numerous table and figures that illustrate the trends and activities in metabolic deal making since 2019.
In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Metabolic Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2019
- Browse metabolic collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Metabolic Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of metabolic trends and structure of deals entered into by leading biopharma companies worldwide.Metabolic Collaboration and Licensing Deals includes:
- Trends in metabolic dealmaking in the biopharma industry
- Overview of collaboration and licensing deal structure
- Directory of metabolic deal records covering pharmaceutical and biotechnology
- The leading metabolic deals by value
- Most active metabolic licensing dealmakers
In Metabolic Collaboration and Licensing Deals, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Metabolic Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in metabolic dealmaking
Chapter 3 - Financial deal terms for metabolic partnering
Chapter 4 - Leading metabolic deals and dealmakers
Chapter 5 - Metabolic contract document directory
Chapter 6 - Metabolic dealmaking by therapeutic target
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4P-Pharma
- 23andMe
- 180 Life Sciences
- Abbisko Therapeutics
- Abbott Laboratories
- AbCellera Biologics
- Abeona Therapeutics
- AcelaBio
- Acenzia
- Aceragen
- Acerus
- Acuitas Therapeutics
- Adaptive Phage Therapeutics
- Adhera Therapeutics
- Advanz Pharma
- AdventHealth
- Aeglea BioTherapeutics
- AEterna Zentaris
- Aevi Genomic Medicine
- AgBiome
- AgeX Therapeutics
- AiCuris
- Ajinomoto
- Akcea Therapeutics
- Akero Therapeutics
- Albert Einstein College of Medicine
- Albireo
- Alexion Pharmaceuticals
- Aligos Therapeutics
- Alimentiv
- AliveCor
- Allele Biotechnology and Pharmaceuticals
- AllerGenis
- Allevi 3D
- Almelo
- Alnylam Pharmaceuticals
- ALR Technologies
- ALTuCELL
- Amarna Therapeutics
- Amazentis
- Ambiopharm
- AM Chemicals
- A Menarini Diagnostics
- American Association for the Study of Liver Diseases
- American Diabetes Association
- Amgen
- Amicus Therapeutics
- AmideBio
- Amolyt Pharma
- AMRA Medical
- Amyris
- Anagram Therapeutics
- Angers University
- Anivive Lifesciences
- Anji Pharma
- Antares Pharma
- Apellis Pharmaceuticals
- Apollon Formularies
- Applied DNA Sciences
- Applied Therapeutics
- APR Applied Pharma Research
- Arbor Biotechnologies
- Arch Biopartners
- Archer Daniels Midland Company
- Arecor
- Argon Medical Devices
- Arjuna Naturals
- Arrowhead Pharmaceuticals
- Arzeda
- Ascendis Pharma
- Ascensia Diabetes Care
- Ascletis
- Asklepios Biopharmaceutical
- Aspect Biosystems
- Astellas Pharma
- Astex Pharmaceuticals
- AstraZeneca
- ATUM
- Avicanna
- Avrobio
- Axcella
- AXIM Biotechnologies
- Axovant Gene Therapies
- Aytu BioPharma
- Baliopharm
- BaoDao Feed
- Basepaws
- Bavarian Brewing & Beverage Institute
- Baxter International
- Bayer
- BCD Bioscience
- Beam Therapeutics
- Beijing University of Chinese Medicine
- Bened Biomedical
- Benuvia Therapeutics
- Berg
- Beta Bionics
- Better Therapeutics
- Beyond Type 1
- Bigfoot Biomedical
- Bill and Melinda Gates Foundation
- Bioadaptives
- biOasis Technologies
- Biocon
- BIOCORP
- Biodexa Pharmaceuticals
- BioHarvest Sciences
- BIOHM Health Inc
- BioLinQ
- Biolojic Design
- BioMed X Innovation Center
- BioPep
- Biosidus
- Biosplice
- Bird Foundation
- Boehringer Ingelheim
- Bond Pet Foods
- Boston Scientific
- BPGbio
- Bracco Imaging
- Brand Institute
- Bridge Biotherapeutics
- Brigham and Women's Hospital
- BrightInsight
- Brightseed
- Broad Institute
- Bruker
- Bruno Farmaceutici
- Bunker Pflanzenextrakte
- c-LEcta
- Cambrooke Therapeutics
- CamDiab
- CAMP4 Therapeutics
- Can-Fite BioPharma
- CANbridge Pharmaceuticals
- Cantex Pharmaceuticals
- Capillary Biomedical
- Capitainer
- Cardiff University
- Cardinal Health
- Cardiovascular Solutions of Central Mississippi
- CASI Pharmaceuticals
- Catalent
- Cellarity
- CELLINK
- Celloram
- Centene
- Center for Genomic Regulation
- Centogene
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Centrus Health Clinics
- Century Therapeutics
- Chiesi Farmaceutici
- Children's Hospital at Montefiore
- Children's Hospital Boston
- ChromaDex
- Cibus Global
- Citrine Medicine
- Civica Rx
- CJ CheilJedang
- Clarus Therapeutics
- Clinigen
- CN Bio
- Code Biotherapeutics
- Codexis
- Columbia University
- Companion Medical
- Conatus Pharmaceuticals
- Consilient Health
- Cooper Aerobics
- Corvium
- Cosmos
- COUR Pharmaceutical
- Covance
- Creative Medical Technologies
- Crinetics
- CRISPR Therapeutics
- Critical Path Institute (C-Path)
- Crossject
- Cukierman & Co Life Sciences
- Cure Genetics
- Cycle Pharmaceuticals
- CymaBay Therapeutics
- Cystic Fibrosis Foundation
- Cytoo
- Dawn Health
- Deargen
- Decode Health
- Defense Health Agency (US)
- DEKA Research and Development
- Delta 4
- Delve Health
- Dewpoint Therapeutics
- DexCom
- Diabeloop
- Diabetes Research Connection
- Diabetes Research Institute
- Diabetes Singapore
- Diamyd Medical
- Dicerna Pharmaceuticals
- DigiLab
- Diomics
- Diurnal
- DKSH
- DNAnexus
- DolCas Biotech
- Dong-A ST
- DreaMed Diabetes
- DSM
- Duke University
- DuPont Pharmaceuticals
- Dyadic International
- Dyno Therapeutics
- EatLove
- Eccogene
- Echosens
- ECMOHO
- EffRx Pharmaceuticals
- Ei.Ventures
- EirGen Pharma
- Elanco
- Elcelyx Therapeutics
- Eleven Biotherapeutics
- Eli Lilly
- ELNA Medical
- Elo Life Systems
- Emmyon
- Enable Biosciences
- ENDRA Life Sciences
- Engitix
- Engrail Therapeutics
- Enogenesis
- Entera Bio
- Enzolytics
- Enzyvant Science
- Epitomee Medical
- Eracal Therapeutics
- Eton Pharmaceuticals
- European Union Regional Development Fund
- European Wellness Biomedical Group
- EVA Pharma
- EverlyWell
- Eversana
- Evgen Pharma
- Evidation Health
- Evo Foods
- EVOQ Therapeutics
- Evotec
- Evozyne
- Ewopharma
- Fermbox Bio
- First Wave Bio
- FitBit
- Flagship Biosciences
- Fondazione San Raffaele
- Fondazione Telethon
- Fonterra
- Food and Drug Administration (FDA)
- Foundation for Diabetes Research
- FUJIFILM Cellular Dynamics
- Fundacion Progreso y Salud
- G3 Therapeutics
- G42 Healthcare
- Gain Therapeutics
- Galapagos
- Galectin Therapeutics
- Galmed Pharmaceuticals
- Gan & Lee
- Gannex Pharma
- GATC Health
- GC Pharma
- GE Healthcare
- GEMMA Biotherapeutics
- Genentech
- General Automation Lab Technologies
- Generation Bio
- Generex Biotechnology
- Genethon
- Genetron Health
- Genevant Sciences
- Genfit
- Genome Quebec
- Genomma Lab Internacional
- Genprex
- George Clinical
- Gilead Sciences
- Ginkgo BioWorks
- Glenmark Pharmaceuticals
- Global Liver Institute
- Glooko
- GlucoModicum
- Glympse Bio
- Glytec
- Goldfinch Bio
- GoodRx
- Graviton Bioscience
- Group K Diagnostics
- GSK
- Hamilton Company
- Hanmi Pharmaceutical
- Hansa Biopharma
- Harbin Pharmaceutical Group
- Harvard Medical School
- Haselmeier
- Hatch Medical
- HAYA Therapeutics
- Health2Sync
- Healthimation
- Health Network Laboratories
- Healthy.io
- Healthy Grain
- HemoShear
- Hepalys Pharma
- HepaTx
- Hepion Pharmaceuticals
- HepQuant
- Hill's Pet Nutrition
- HistoIndex
- HitGen
- HK inno.N
- Horizon Discovery
- Horizon Therapeutics
- Humacyte
- I-mab
- iECURE
- Imagine Pharmaceuticals
- Imaware
- Immedica
- Immusoft
- Imperial College London
- Indiana University
- Ingredion
- Innovate UK
- Innovation Zed
- Innovent Biologics
- Inserm
- Insilico Medicine
- Insitro
- InSphero
- Institute of Endocrinology
- Metabolism
- and Reproduction
- Institut National Recherche Agronomique
- Insulet
- Intercept Pharmaceuticals
- International Diabetes Federation (IDF)
- International Niemann-Pick Disease Registry
- Inventiva
- Invitae
- Ionis Pharmaceuticals
- Ipsen
- IQVIA
- Ironwood Pharmaceuticals
- iSage Rx
- Itochu
- iTolerance
- Jackson Laboratory
- Jadeite Medicines
- Janssen Pharmaceuticals
- Janssen Research & Development
- Janssen Therapeutics
- Jasper Therapeutics
- JCR Pharmaceuticals
- Jennewein Biotechnologie
- Jiangsu Chia Tai Tianqing Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- Jinggangshan University
- Johns Hopkins Medicine (JHM)
- Johns Hopkins University
- Journey Medical
- Jumpcan Pharmaceutical
- Juntendo University
- Juvenescence
- Juvenile Diabetes Research Foundation
- Kadimastem
- Kahn-Sagol-Maccabi
- Kaken Pharmaceutical
- Kaleido Biosciences
- Kalsec
- Katana Pharmaceuticals
- Klue
- Know Labs
- Kore
- Kyowa Hakko Kirin
- Labcyte
- Laboratory Corporation of America
- Lannett
- Lark Technologies
- Launch Therapeutics
- Leona M and Harry B Helmsley Charitable Trust
- Lexicon Pharmaceuticals
- LG Life Sciences
- Life Genomics AB
- LifeOmic
- LifeScan
- Lipigon Pharmaceuticals
- Lipocine
- Livongo Health
- LogicBio Therapeutics
- Lonza
- LUCA Science
- Lumen Biomedical
- Luminex
- Lumos Pharma
- Lurie Children's Hospital of Chicago
- LyGenesis
- Lygos
- LY Research
- Lysando
- Lysogene
- mAbXience
- Mammoth Biosciences
- Mandos
- MannKind Biopharmaceuticals
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Mass General Brigham
- Max Biopharma
- Mayo Clinic
- Maze Therapeutics
- McGill University
- McQuade Center for Strategic Research and Development
- Meatable
- MEDIAN Technologies
- Medical College of Wisconsin
- Medical University of South Carolina
- MediciNova
- Medicox
- MedImmune
- Medipal Holdings
- Medison Pharma
- Medtronic
- Meitheal Pharmaceuticals
- Melior Pharmaceuticals
- Merck and Co
- Merck KGaA
- Merieux NutriSciences
- Merz
- Mesh Bio
- Metaba
- Meta Healthcare
- MetaSight Diagnostics
- MiNA Therapeutics
- Minerva Foods
- Minovia Therapeutics
- Miromatrix Medical
- Mirum Pharmaceuticals
- Mission Bio
- Mitobridge
- MJH Life Sciences
- Moderna
- Modular Medical
- Mount Sinai Health System
- mPulse Mobile
- MRM Health
- MThera Pharma
- MultiOmic Health
- Murdoch University
- MyBiotics Pharma
- MySugarWatch DuoPack
- Namocell
- NAMUH
- National Cerebral and Cardiovascular Disease Research Center
- National Heart
- Lung and Blood Institute
- National Institute of Arthritis and Musculoskeletal Diseases
- National Institute of Child Health and Human Development
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Organization for Rare Disorders
- National Research Council Canada
- National University of Singapore
- Navidea Biopharmaceuticals
- Nebraska Medicine
- Nemaura Medical
- Nemysis
- Neogen
- Neo Gene Pharm
- Neomorph
- NephroDI Therapeutics
- Nestle Health Science
- Neuraxpharm
- NeuroBo Pharmaceuticals
- Neurodon
- NeuroFront
- Newsoara Biopharma
- New Wave Ventures
- Neximmune
- NGM Biopharmaceuticals
- Nicoya
- Nimbus Therapeutics
- NIMIUM Therapeutics
- NLC Pharma
- Northwestern University
- Novaremed
- Novartis
- Novasep
- Novitium Pharma
- Novo Integrated Sciences
- Novo Nordisk
- Nuformix
- Numares
- NutraFuels
- Nutrition21
- Ocean Spray Cranberries
- Ochre Bio
- Ohio State University
- OliX Pharmaceuticals
- Olympus
- Omega Therapeutics
- OmniaBio
- One World Products
- Open Book Extracts
- OPKO Biologics
- OPKO Health
- Optithera
- Optomed
- Oramed Pharmaceuticals
- Orchard Therapeutics
- Oregon Health Sciences University
- Orgenesis
- Origin Agritech
- OrphanPacific
- OrsoBio
- OSE Immunotherapeutics
- OSI Pharmaceuticals
- Oslo University Hospital
- Otsuka
- Ovation
- Pancryos
- Pandion Therapeutics
- Paraza Pharma
- Particles for Humanity
- Parvus Therapeutics
- Passage Bio
- PathAI
- Pathalys Pharma
- Patia
- Penn State Microbiome Center
- PeptiDream
- Performance Inspired Nutrition
- PerkinElmer
- Perspectum Diagnostics
- Pfizer
- PharmaCyte Biotech
- Pharmanest
- Pharmanovia
- Pharmathen
- Pharmavite
- Phenex
- Phillips-Medisize
- PhoreMost
- Phytolon
- Piramal
- Pliant Therapeutics
- Pluristem Therapeutics
- Pluristyx
- Polyganics
- Population Health Partners
- Precision Diabetes
- Pressure BioSciences
- Procyon Technologies
- Profil Institute for Clinical Research
- ProLynx
- Promethera Biosciences
- Provention Bio
- Psyence Therapeutics
- Pulmatrix
- Purnovate
- Quell Therapeutics
- Quest Diagnostics
- Radius Health
- Rallybio
- Rare Disease Company Coalition
- Raziel Therapeutics
- RC2
- Readout Health
- Reata Pharmaceuticals
- Recordati
- Redox
- Redwire
- Regenxbio
- Regor Therapeutics
- Relief Therapeutics
- Remedium Bio
- RenalytixAI
- Renown Institute for Health Innovation
- Resolution Therapeutics
- Revive Therapeutics
- Reyon Pharmaceuticals
- Rezolute
- Rho
- Rimidi
- Ripe Technology
- Roche
- Roche Diagnostics
- SafeTraces
- Sagimet Biosciences
- Salix Pharmaceuticals
- Sandhill One
- Sanofi
- Sanofi US Services
- Sanwa Kagaku Kenkyusho
- Science 37
- Scientific Research Council
- Scivita Medical Technology
- Sciwind Biosciences
- SCM Pharma
- Seal Rock Therapeutics
- Second Genome
- Selecta Biosciences
- Senda Biosciences
- Senseonics
- Senti Biosciences
- Seoul National University
- Seraxis
- Sernova
- SFC Fluidics
- Shanghai Jiao Tong University
- Shenzhen Chipscreen Biosciences
- Shionogi
- Shionogi Pharma
- Siemens Healthineers
- Sigilon Therapeutics
- Silence Therapeutics
- Singapore General Hospital
- Sino Biopharmaceutical
- Sirion Biotech
- Sirona Biochem
- SocialDiabetes
- Solarea Bio
- SomaLogic
- SOOIL Development Company
- Sookmyung Women's University
- Sosei
- Spark Therapeutics
- Stealth BioTherapeutics
- Steno Diabetes Center
- SteroTherapeutics
- Stevanato
- Sumitomo Dainippon Pharma
- Summit Clinical Research
- Sun Genomics
- Surrozen
- Suzhou Ribo Life Sciences
- Synbiotech
- Synbiotic Health
- SynerK
- Synlogic
- Synspira
- Synthetic Biologics
- T-Cell Protect Hellas
- Taisho Pharmaceutical
- TaiwanJ Pharmaceuticals
- Takara Bio
- Takeda Pharmaceutical
- Tandem Diabetes Care
- Target RWE
- Tate & Lyle
- Taysha Gene Therapies
- Teijin
- Terns Pharmaceuticals
- Terumo
- TeselaGen
- Tespo
- Tetra Bio-Pharma
- Tetris Pharma
- Texas A&M University
- The Healthy Aging Company
- TheracosBio
- Thorne HealthTech
- Tianjin JuveStar Biotech
- Tiburio Therapeutics
- Tidepool
- Tnuva Group
- Todos Medical
- Tolmar
- Tome Biosciences
- Tonghua Dongbao Pharma
- TONIX Pharmaceuticals
- Torrent Pharmaceuticals
- Tottori University
- TPMENA
- TransThera
- TreeFrog Therapeutics
- Trovita Health Science
- True Diagnostics
- TRx Biosciences
- Twist Bioscience
- UK Biobank
- Ultragenyx Pharmaceuticals
- Universe Pharmaceuticals
- University Libre of Brussels
- University of Alberta
- University of British Columbia
- University of California
- San Diego
- University of California
- San Diego (UCSD) School of Medicine
- University of California Irvine
- University of California Los Angeles
- University of California San Francisco
- University of Chicago
- University of Colorado
- University of Edinburgh
- University of Florida
- University of Geneva
- University of Maryland School of Medicine
- University of Massachusetts
- University of Miami
- University of Nebraska
- University of New Mexico
- University of North Carolina
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Sheffield
- University of Technology Sydney
- University of Texas
- University of Toronto
- University of Virginia
- University of Washington
- University of West Indies
- University of Wisconsin-Madison
- University Paris Diderot
- UP International
- Upsher-Smith
- USANA Health Science
- UW Medicine
- Valbiotis
- Valley Oils Partners
- Valo Health
- Vanderbilt University
- VELL Health
- Ventus Therapeutics
- Verantos
- Veravas
- Versiti Blood Research Institute
- Vertex Pharmaceuticals
- Vertice Pharma
- Verve Therapeutics
- VGI Health Technology
- ViaCyte
- Vifor Pharma
- Viome
- Vipergen
- VIPUN Medical
- Viralgen
- Virginia Commonwealth University
- Virginia Tech
- Virtual Health Partners
- VisionQuest Biomedical
- Visirna Therapeutics
- VistaGen Therapeutics
- Vitro Biopharma
- Vivet Therapeutics
- Vivici
- VOTIS Subdermal Imaging Technologies
- vTv Therapeutics
- Wake Forest University
- Wake Forest University School of Medicine
- Wanbang Biopharmaceuticals
- Washington University in St Louis
- WaVe Lifesciences
- Weizmann Institute
- WellDoc
- WellGen
- Willow Biosciences
- Winhealth Pharma Group
- W L Gore
- XERIS Pharmaceuticals
- Xlife Sciences
- Xoma
- XtalPi
- Yale University
- Yeda Research and Development Company
- Yili Industrial Group
- Ymir Genomics
- Ypsomed
- Yuhan Corporation
- Zealand Pharma
- Zelira Therapeutics
- Zhejiang Hisun Pharmaceutical
- ZyVersa Therapeutics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
